Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting

Supportive Care in Cancer

Volumn 22, Issue 3, 2014, Pages 627-634

  Ben Arye, Eran ^a,b   Kruger, Dikla ^a,b   Samuels, Noah ^a   Keinan Boker, Lital ^c,d   Shalom, Tamar ^a   Schiff, Elad ^d,e  

^a CLALIT HEALTH SERVICES   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

^e BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Adherence; Complementary and alternative medicine; Doctor patient communication; Integrative medicine; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RECURRENCE; CONSULTATION; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; INTEGRATIVE MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICATION COMPLIANCE; MIDDLE AGED; ONCOLOGY; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SELF REPORT; TREATMENT INDICATION;

AGED; FEMALE; HEALTH PERSONNEL; HUMANS; INTEGRATIVE MEDICINE; MALE; MIDDLE AGED; NEOPLASMS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION;

EID: 84895869697     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-2016-z     Document Type: Article

References (20)

1. Navo M, Phan J, Vaughan C, Palmer J, Michaud L, JonesK, Bodurka D, Basen-Engquist K, Hortobagyi G, Kavanagh J, Smith J (2004) An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 22(4):671-677 (Pubitemid 41095070)
2. Gansler T, Kaw C, Crammer C, Smith T (2008) A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer 113(5):1048-1057
3. Frenkel M, Cohen L, Peterson N et al (2010) Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther 9(3):276-283
4. Deng G (2008) Integrative cancer care in a US academic cancer centre: The Memorial Sloan-Kettering Experience. Curr Oncol 15(Suppl 2):s108, es68-71
5. Seely D, Weeks L (2012) A systematic review of integrative oncology programs. Curr Oncol 19:e436-e461
6. Deng G, Frenkel M, Cohen L et al (2009) Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 7(3):85-120
7. Gaboury I, April KT, Verhoef M (2012) A qualitative study on the term CAM: is there a need to reinvent the wheel? BMC Complement Altern Med 12:131
8. Caspi O, Sechrest L, Pitluk HC, Marshall CL, Bell IR, Nichter M (2003) On the definition of complementary, alternative, and integrative medicine: societal mega-stereotypes vs. the patients' perspectives. Altern Ther Health Med 9(6):58-62 (Pubitemid 37362885)
9. Ben-Arye E, Schiff E, Golan O (2008) Ethical issues in integrative oncology. Hematol/Oncol Clin N Am 22(4):737-753
10. Ben-Arye E, Schiff E, Zollman C, Heusser P, Mountford P, Frenkel M, Bar-Sela G, Lavie O (2013) Integrating complementary medicine in supportive cancer care models across four continents. Med Oncol 30(2):511
11. Ben-Arye E, Schiff E, Shapira C, Frenkel M, Shalom T, Steiner M (2012) Modeling an integrative oncology program within a community-centered oncology service in Israel. Patient Educ Couns 89(3):423-429
12. Ben-Arye E, Schiff E, SteinerM, Keshet Y, Lavie O (2012) Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care. Int J Gynecol Cancer 22(1):146-153
13. Oldenmenger W, de Raaf P, de Klerk C, van der Rijt C (2012) Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review. J Pain SymptomManag 45(6):1083-1093. doi:10.1016/j.jpainsymman.2012.06.007
14. Paterson C, Thomas K,Manasse A, Cooke H, PeaceG(2007) Measure Yourself Concerns and Wellbeing (MYCaW): an individualized questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15(1):38-45 (Pubitemid 46359915)
15. Lazenby M, Khatib J, Al-Khair F, Neamat M (2013) Psychometric properties of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-being (FACIT-Sp) in an Arabic-speaking, predominantly Muslim population. Psycho-oncology 22(1):220-227
16. Liang S, Yates P, Edwards H, Tsay S (2008) Factors influencing opioid-taking self-efficacy and analgesic adherence in Taiwanese outpatients with cancer. Psycho-oncology 17(11):1100-1107
17. Moynihan C, Norman A, Barbachano Y, Burchell L, Huddart R, Dearnaley D, Horwich A (2009) Prospective study of factors predicting adherence to medical advice in men with testicular cancer. J Clin Oncol 27(13):2144-2150
18. Kahn K, Schneider E, Malin J, Adams J, Epstein A (2007) Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care 45(5):431-439
19. Neymark N, Crott R (2005) Impact of emesis on clinical and economic outcomes of cancer therapy with highly emetogenic chemotherapy regimens: a retrospective analysis of three clinical trials. Support Care Cancer 13(10):812-818 (Pubitemid 41414022)
20. Frenkel M, Cohen L (2008) Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematol/Oncol Clin N Am 22(4):727-736